Niacinamide cannot clear fungal acne, because fungal acne is not acne at all — it is a yeast infection of the hair follicle that needs antifungal medication. Niacinamide is safe to keep using on skin prone to it, and it may help with the oiliness and redness sitting alongside the real problem, but it will not eradicate the organism causing the breakout. That distinction matters more than it sounds. Fungal acne is routinely mistaken for ordinary acne, and the months spent treating it with acne products are months the yeast keeps multiplying — sometimes with the acne treatment itself making things worse.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What fungal acne actually is
- What the evidence on niacinamide covers — and what it does not
- Why niacinamide is still safe to use
- The acne treatments that make it worse
- What treatment actually looks like
- Where niacinamide fits in a fungal-acne routine
- Frequently Asked Questions
What fungal acne actually is
Fungal acne's clinical name is Malassezia folliculitis. It is an overgrowth of Malassezia, a yeast that lives normally on human skin, inside the hair follicle. The result is a crop of small, uniform, itchy bumps, usually on the chest, back, shoulders or forehead.
According to a September 2025 review in the Journal of Fungi by Chalupczak and Lipner, the condition closely mimics acne vulgaris and is commonly misdiagnosed as it — and that misdiagnosis delays correct treatment. The same review notes that the mainstay of treatment is antifungal medication, not acne medication, and that topical and oral antifungals are highly effective, though relapses are common. So the question of whether a given skincare ingredient "treats" fungal acne is really a question about whether it kills or suppresses a yeast. Niacinamide was never shown to do that.
What the evidence on niacinamide covers — and what it does not
No peer-reviewed clinical trial has tested niacinamide as a treatment for Malassezia folliculitis. The only direct claim that nicotinamide inhibits Malassezia growth appears in a 2018 US patent disclosure, which is a commercial filing rather than a published study. A patent claim is not clinical evidence, and nothing has followed it into the trial literature.
Niacinamide's documented acne evidence is for acne vulgaris — the bacteria-and-sebum condition most people mean by "acne." In a 12-week split-face, double-blind trial of 21 patients aged 18 to 36, published by Kaewsanit and colleagues in the Journal of Clinical and Aesthetic Dermatology, 5% niacinamide with 2.5% benzoyl peroxide significantly reduced lesion counts and sebum from baseline, with a greater reduction in non-inflammatory lesions than the control side. That is a real result on a real condition. It is not transferable to a yeast infection, because the mechanism it describes — less oil, fewer clogged pores, less inflammation — does not remove the organism.
Why niacinamide is still safe to use
Readers with fungal acne often strip their routines down to almost nothing, because so many ingredients genuinely do feed the yeast. Niacinamide survives that cull. Malassezia yeasts cannot synthesize their own C14 and C16 fatty acids and must scavenge lipids from sebum, which is why fatty acids, oils, esters and polysorbates in skincare can feed the organism — as described in a 2020 review in Frontiers in Cellular and Infection Microbiology.
Niacinamide is a water-soluble vitamin and supplies no such lipid. The practical point is about the whole formula, not the active. A niacinamide serum in a lightweight, oil-free base is a different proposition from a niacinamide-containing cream built on esters and plant oils. Read the full ingredient list, not the front of the bottle.
The acne treatments that make it worse
This is the part most worth knowing, because it reverses the usual intuition that any acne product is at least neutral. DermNet NZ reports that Malassezia folliculitis becomes more prominent when accompanying acne is treated with tetracyclines — oral antibiotics widely prescribed for acne — and that "steroid acne" is often Malassezia folliculitis precipitated by potent topical or systemic corticosteroids.
A Cutis review puts recent antibiotic exposure as the dominant risk factor: more than 75% of patients in one series had recently received antibiotics for acne, with corticosteroid use and immunosuppression as additional predisposing factors. Signs worth raising with a clinician:.
- Bumps that itch, rather than hurt
- Small lesions of strikingly uniform size, with no blackheads among them
- Clusters on the chest, back, shoulders or hairline
- Breakouts that appeared or worsened after a course of oral antibiotics for acne
- Breakouts that appeared after topical or systemic steroid use
What treatment actually looks like
Diagnosis is confirmed, not assumed. The Journal of Fungi review lists KOH direct microscopy, dermoscopy, Wood's lamp and histopathology as the confirmation methods, and its authors warn specifically against patients self-applying antifungals without a confirmed diagnosis. The treatment numbers show why oral therapy tends to lead.
In a randomized open-label trial summarized in the evidence-based Danish guidelines in Acta Dermato-Venereologica, 200 mg per day of oral itraconazole or fluconazole for seven days produced 80% and 97% mycological eradication at day 30 — but 23% of patients on both drugs had treatment failure or relapse two months after stopping. Topical ketoconazole alone cured 12% of patients in one case series, against 75% for oral ketoconazole alone or combined with topical, with consistent recurrence three to four months after stopping. That recurrence pattern is the reason maintenance or prophylactic therapy is recommended for repeated recurrences. It also sets the realistic expectation: clearing it once is normal, and so is needing a plan for the next time.
Where niacinamide fits in a fungal-acne routine
Treat it as a supporting ingredient for the skin around the problem, not the fix. If you have both conditions at once — which is common, since the two look alike and often coexist — niacinamide's documented work on sebum and non-inflammatory lesions applies to the acne vulgaris half. A workable sequence: Niacinamide can at best address the oil and inflammation side of a lesion count, and cannot be expected to clear a confirmed yeast infection.
- Get the diagnosis confirmed before buying anything
- Follow the prescribed antifungal course to its end, including any maintenance step
- Keep the rest of the routine free of oils, fatty acids, esters and polysorbates during treatment
- Keep or add niacinamide in a lipid-free base for oil and redness, with no expectation it treats the yeast
- Flag any history of recent oral antibiotics or steroids, since it changes what a clinician looks for
Frequently Asked Questions
Can niacinamide feed Malassezia the way oils do?
No. The Frontiers review explains that Malassezia must scavenge C14/C16 fatty acids from sebum; niacinamide is water-soluble and supplies no such lipid. The base a product is formulated in is the thing to check.
If my acne antibiotics stopped working, is that a sign of fungal acne?
It can be. DermNet NZ notes Malassezia folliculitis becomes more prominent when accompanying acne is treated with tetracyclines, and the Cutis review found over 75% of patients in one series had recently taken antibiotics for acne.
Should I just buy an antifungal shampoo and try it?
The Journal of Fungi reviewers warn specifically against self-applying antifungals without a confirmed diagnosis, which needs KOH microscopy, dermoscopy, Wood's lamp or histopathology.
How long does treatment hold?
Not indefinitely without maintenance. The Danish guidelines report 23% treatment failure or relapse two months after stopping oral therapy, and recurrence three to four months after stopping topical ketoconazole.